药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methylphenobarbital
Melengestrol
The risk or severity of adverse effects can be increased when Docetaxel is combined with Melengestrol.
Methylphenobarbital
Tepoxalin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Tepoxalin.
Methylphenobarbital
Fluprednisolone
The risk or severity of adverse effects can be increased when Docetaxel is combined with Fluprednisolone.
Methylphenobarbital
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Docetaxel is combined with Antilymphocyte immunoglobulin (horse).
Methylphenobarbital
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Docetaxel is combined with Peginterferon beta-1a.
Methylphenobarbital
Tixocortol
The risk or severity of adverse effects can be increased when Docetaxel is combined with Tixocortol.
Methylphenobarbital
Vilanterol
The risk or severity of adverse effects can be increased when Docetaxel is combined with Vilanterol.
Methylphenobarbital
Dinutuximab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Dinutuximab.
Methylphenobarbital
Blinatumomab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Blinatumomab.
Methylphenobarbital
Vedolizumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Vedolizumab.
Methylphenobarbital
Obinutuzumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Obinutuzumab.
Methylphenobarbital
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Docetaxel is combined with Dimethyl fumarate.
Methylphenobarbital
Carfilzomib
The risk or severity of adverse effects can be increased when Docetaxel is combined with Carfilzomib.
Methylphenobarbital
Teriflunomide
The risk or severity of adverse effects can be increased when Docetaxel is combined with Teriflunomide.
Methylphenobarbital
Belimumab
The risk or severity of adverse effects can be increased when Docetaxel is combined with Belimumab.
Methylphenobarbital
Eribulin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Eribulin.
Methylphenobarbital
Wortmannin
The risk or severity of adverse effects can be increased when Docetaxel is combined with Wortmannin.
Methylphenobarbital
Pralatrexate
The risk or severity of adverse effects can be increased when Docetaxel is combined with Pralatrexate.
Methylphenobarbital
Bendamustine
The risk or severity of adverse effects can be increased when Docetaxel is combined with Bendamustine.
Methylphenobarbital
Belatacept
The risk or severity of adverse effects can be increased when Docetaxel is combined with Belatacept.